Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 305

1.

Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol.

Schwarz UI, Hanso H, Oertel R, Miehlke S, Kuhlisch E, Glaeser H, Hitzl M, Dresser GK, Kim RB, Kirch W.

Clin Pharmacol Ther. 2007 May;81(5):669-78. Epub 2007 Mar 28.

PMID:
17392718
[PubMed - indexed for MEDLINE]
2.

Grapefruit juice ingestion significantly reduces talinolol bioavailability.

Schwarz UI, Seemann D, Oertel R, Miehlke S, Kuhlisch E, Fromm MF, Kim RB, Bailey DG, Kirch W.

Clin Pharmacol Ther. 2005 Apr;77(4):291-301.

PMID:
15903127
[PubMed - indexed for MEDLINE]
3.

Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction.

Westphal K, Weinbrenner A, Zschiesche M, Franke G, Knoke M, Oertel R, Fritz P, von Richter O, Warzok R, Hachenberg T, Kauffmann HM, Schrenk D, Terhaag B, Kroemer HK, Siegmund W.

Clin Pharmacol Ther. 2000 Oct;68(4):345-55.

PMID:
11061574
[PubMed - indexed for MEDLINE]
4.

Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans.

Giessmann T, May K, Modess C, Wegner D, Hecker U, Zschiesche M, Dazert P, Grube M, Schroeder E, Warzok R, Cascorbi I, Kroemer HK, Siegmund W.

Clin Pharmacol Ther. 2004 Sep;76(3):192-200.

PMID:
15371980
[PubMed - indexed for MEDLINE]
5.

St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4.

Dürr D, Stieger B, Kullak-Ublick GA, Rentsch KM, Steinert HC, Meier PJ, Fattinger K.

Clin Pharmacol Ther. 2000 Dec;68(6):598-604.

PMID:
11180019
[PubMed - indexed for MEDLINE]
6.

The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.

Wang Z, Gorski JC, Hamman MA, Huang SM, Lesko LJ, Hall SD.

Clin Pharmacol Ther. 2001 Oct;70(4):317-26.

PMID:
11673747
[PubMed - indexed for MEDLINE]
7.

P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans.

Schwarz UI, Gramatté T, Krappweis J, Oertel R, Kirch W.

Int J Clin Pharmacol Ther. 2000 Apr;38(4):161-7.

PMID:
10783825
[PubMed - indexed for MEDLINE]
8.

The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.

Siegmund W, Ludwig K, Giessmann T, Dazert P, Schroeder E, Sperker B, Warzok R, Kroemer HK, Cascorbi I.

Clin Pharmacol Ther. 2002 Nov;72(5):572-83.

PMID:
12426521
[PubMed - indexed for MEDLINE]
9.

Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects.

Dresser GK, Schwarz UI, Wilkinson GR, Kim RB.

Clin Pharmacol Ther. 2003 Jan;73(1):41-50.

PMID:
12545142
[PubMed - indexed for MEDLINE]
10.

Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers.

Han Y, Guo D, Chen Y, Tan ZR, Zhou HH.

Xenobiotica. 2009 Sep;39(9):694-9. doi: 10.1080/00498250903060077.

PMID:
19555315
[PubMed - indexed for MEDLINE]
11.

Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein.

Westphal K, Weinbrenner A, Giessmann T, Stuhr M, Franke G, Zschiesche M, Oertel R, Terhaag B, Kroemer HK, Siegmund W.

Clin Pharmacol Ther. 2000 Jul;68(1):6-12.

PMID:
10945310
[PubMed - indexed for MEDLINE]
12.

Unexpected effect of verapamil on oral bioavailability of the beta-blocker talinolol in humans.

Schwarz UI, Gramatté T, Krappweis J, Berndt A, Oertel R, von Richter O, Kirch W.

Clin Pharmacol Ther. 1999 Mar;65(3):283-90.

PMID:
10096260
[PubMed - indexed for MEDLINE]
13.

Effect of levothyroxine administration on intestinal P-glycoprotein expression: consequences for drug disposition.

Siegmund W, Altmannsberger S, Paneitz A, Hecker U, Zschiesche M, Franke G, Meng W, Warzok R, Schroeder E, Sperker B, Terhaag B, Cascorbi I, Kroemer HK.

Clin Pharmacol Ther. 2002 Sep;72(3):256-64.

PMID:
12235446
[PubMed - indexed for MEDLINE]
14.

Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics.

Rengelshausen J, Banfield M, Riedel KD, Burhenne J, Weiss J, Thomsen T, Walter-Sack I, Haefeli WE, Mikus G.

Clin Pharmacol Ther. 2005 Jul;78(1):25-33.

PMID:
16003289
[PubMed - indexed for MEDLINE]
15.

Simvastatin does not influence the intestinal P-glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms.

Bernsdorf A, Giessmann T, Modess C, Wegner D, Igelbrink S, Hecker U, Haenisch S, Cascorbi I, Terhaag B, Siegmund W.

Br J Clin Pharmacol. 2006 Apr;61(4):440-50.

PMID:
16542205
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The interaction between St John's wort and an oral contraceptive.

Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada N, Adigun AQ, Hilligoss JK, Miller M, Gorski JC.

Clin Pharmacol Ther. 2003 Dec;74(6):525-35.

PMID:
14663455
[PubMed - indexed for MEDLINE]
17.

Effect of St John's wort on the pharmacokinetics of fexofenadine.

Wang Z, Hamman MA, Huang SM, Lesko LJ, Hall SD.

Clin Pharmacol Ther. 2002 Jun;71(6):414-20.

PMID:
12087344
[PubMed - indexed for MEDLINE]
18.

MDR1 genotype do not influence the absorption of a single oral dose of 100 mg talinolol in healthy Chinese males.

Zhang WX, Chen GL, Zhang W, Tan ZR, Liu J, Zhou G, Hu DL, Zhou HH.

Clin Chim Acta. 2005 Sep;359(1-2):46-52.

PMID:
16170863
[PubMed - indexed for MEDLINE]
19.

St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism.

Tannergren C, Engman H, Knutson L, Hedeland M, Bondesson U, Lennernäs H.

Clin Pharmacol Ther. 2004 Apr;75(4):298-309.

PMID:
15060508
[PubMed - indexed for MEDLINE]
20.

Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans.

Becquemont L, Glaeser H, Drescher S, Hitzl M, Simon N, Murdter TE, Heinkele G, Hofmann U, Schaefer C, Burk O, Verstuyft C, Eichelbaum M, Fromm MF.

Clin Pharmacol Ther. 2006 May;79(5):449-60. Epub 2006 Apr 11.

PMID:
16678547
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk